These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

172 related articles for article (PubMed ID: 31385632)

  • 1. Switching between Crystallization from the Glassy and the Undercooled Liquid Phase in Phase Change Material Ge
    Pries J; Wei S; Wuttig M; Lucas P
    Adv Mater; 2019 Sep; 31(39):e1900784. PubMed ID: 31385632
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Thermodynamics, molecular mobility and crystallization kinetics of amorphous griseofulvin.
    Zhou D; Zhang GG; Law D; Grant DJ; Schmitt EA
    Mol Pharm; 2008; 5(6):927-36. PubMed ID: 19434849
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Crystallization of indomethacin from the amorphous state below and above its glass transition temperature.
    Yoshioka M; Hancock BC; Zografi G
    J Pharm Sci; 1994 Dec; 83(12):1700-5. PubMed ID: 7891297
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Reversible amorphous-crystalline phase changes in a wide range of Se(1-x)Te(x) alloys studied using ultrafast differential scanning calorimetry.
    Vermeulen PA; Momand J; Kooi BJ
    J Chem Phys; 2014 Jul; 141(2):024502. PubMed ID: 25028022
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relaxation dynamics and crystallization study of sildenafil in the liquid and glassy states.
    Kolodziejczyk K; Paluch M; Grzybowska K; Grzybowski A; Wojnarowska Z; Hawelek L; Ziolo JD
    Mol Pharm; 2013 Jun; 10(6):2270-82. PubMed ID: 23594226
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Crystallization kinetics and molecular mobility of an amorphous active pharmaceutical ingredient: A case study with Biclotymol.
    Schammé B; Couvrat N; Malpeli P; Delbreilh L; Dupray V; Dargent É; Coquerel G
    Int J Pharm; 2015 Jul; 490(1-2):248-57. PubMed ID: 26003417
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dielectric study of the molecular mobility and the isothermal crystallization kinetics of an amorphous pharmaceutical drug substance.
    Alie J; Menegotto J; Cardon P; Duplaa H; Caron A; Lacabanne C; Bauer M
    J Pharm Sci; 2004 Jan; 93(1):218-33. PubMed ID: 14648651
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fast crystallization below the glass transition temperature in hyperquenched systems.
    Lucas P; Takeda W; Pries J; Benke-Jacob J; Wuttig M
    J Chem Phys; 2023 Feb; 158(5):054502. PubMed ID: 36754790
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Phase transformations undergone by Triton X-100 probed by differential scanning calorimetry and dielectric relaxation spectroscopy.
    Merino EG; Rodrigues C; Viciosa MT; Melo C; Sotomayor J; Dionísio M; Correia NT
    J Phys Chem B; 2011 Nov; 115(43):12336-47. PubMed ID: 21928821
    [TBL] [Abstract][Full Text] [Related]  

  • 10. What We Need to Know about Solid-State Isothermal Crystallization of Organic Molecules from the Amorphous State below the Glass Transition Temperature.
    Newman A; Zografi G
    Mol Pharm; 2020 Jun; 17(6):1761-1777. PubMed ID: 32275832
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Molecular mobility of amorphous pharmaceutical solids below their glass transition temperatures.
    Hancock BC; Shamblin SL; Zografi G
    Pharm Res; 1995 Jun; 12(6):799-806. PubMed ID: 7667182
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Physical stability of drugs after storage above and below the glass transition temperature: Relationship to glass-forming ability.
    Alhalaweh A; Alzghoul A; Mahlin D; Bergström CAS
    Int J Pharm; 2015 Nov; 495(1):312-317. PubMed ID: 26341321
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Molecular Dynamics and Physical Stability of Pharmaceutical Co-amorphous Systems: Correlation Between Structural Relaxation Times Measured by Kohlrausch-Williams-Watts With the Width of the Glass Transition Temperature (ΔT
    Chieng N; Teo X; Cheah MH; Choo ML; Chung J; Hew TK; Keng PS
    J Pharm Sci; 2019 Dec; 108(12):3848-3858. PubMed ID: 31542436
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Factors influencing crystal growth rates from undercooled liquids of pharmaceutical compounds.
    Trasi NS; Baird JA; Kestur US; Taylor LS
    J Phys Chem B; 2014 Aug; 118(33):9974-82. PubMed ID: 25076138
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Nanoconfinement Effects on the Glass Transition and Crystallization Behaviors of Nifedipine.
    Cheng S; McKenna GB
    Mol Pharm; 2019 Feb; 16(2):856-866. PubMed ID: 30615456
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular relaxation behavior and isothermal crystallization above glass transition temperature of amorphous hesperetin.
    Shete G; Khomane KS; Bansal AK
    J Pharm Sci; 2014 Jan; 103(1):167-78. PubMed ID: 24186540
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relaxation Dynamics vs Crystallization Kinetics in the Amorphous State: The Case of Stiripentol.
    Ruiz GN; Romanini M; Barrio M; Tamarit JL; Pardo LC; Macovez R
    Mol Pharm; 2017 Nov; 14(11):3636-3643. PubMed ID: 28915351
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Crystallization near glass transition: transition from diffusion-controlled to diffusionless crystal growth studied with seven polymorphs.
    Sun Y; Xi H; Chen S; Ediger MD; Yu L
    J Phys Chem B; 2008 May; 112(18):5594-601. PubMed ID: 18407712
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Crystallization Kinetics of a Liquid-Forming 2D Coordination Polymer.
    Das C; Nishiguchi T; Fan Z; Horike S
    Nano Lett; 2022 Dec; 22(23):9372-9379. PubMed ID: 36441580
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Molecular mobility of amorphous S-flurbiprofen: a dielectric relaxation spectroscopy approach.
    Rodrigues AC; Viciosa MT; Danède F; Affouard F; Correia NT
    Mol Pharm; 2014 Jan; 11(1):112-30. PubMed ID: 24215236
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.